Polaris Group (TPE:6550)
39.50
+0.70 (1.80%)
Jun 4, 2025, 1:35 PM CST
Polaris Group Revenue
Polaris Group had revenue of 8.43M TWD in the quarter ending March 31, 2025, a decrease of -69.64%. This brings the company's revenue in the last twelve months to 87.67M, up 149.87% year-over-year. In the year 2024, Polaris Group had annual revenue of 107.00M with 1,330.29% growth.
Revenue (ttm)
87.67M
Revenue Growth
+149.87%
P/S Ratio
340.97
Revenue / Employee
531.34K
Employees
165
Market Cap
29.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107.00M | 99.52M | 1,330.29% |
Dec 31, 2023 | 7.48M | 1.04M | 16.18% |
Dec 31, 2022 | 6.44M | -8.60M | -57.19% |
Dec 31, 2021 | 15.04M | 5.63M | 59.84% |
Dec 31, 2020 | 9.41M | - | - |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Center Laboratories | 1.63B |
Oneness Biotech | 117.33M |
Lumosa Therapeutics | 43.59M |
Pegavision | 6.69B |